ENT | new-work-site

Compounding for the Ears, Nose and Throat

Do you have patients suffering from chronic recurrent or resistant sinus infections? Have you been battling allergies or constant infections with no relief? HWCP is proud to offer LoxaSperse™ and the NasoNeb® Nasal Nebulizer available now.

LoxaSperse™ is an innovative base used in compounding nasal nebulizations and irrigations. It allows multiple active ingredients with varying solubilities to be incorporated into a single dosage form making it easier to deliver the medication to the site of infection.

Benefits:
• Increases the solubility and dispersibility of active ingredients, potentially improving absorption performance.
• Allows for multi-drug therapy combinations, giving you more power to customize medication, simplify therapy regimens and potentially improve patient compliance.
• Enables an extended beyond-use date consistent with USP guidelines for anhydrous dosage forms, since the powder contents (from a capsule or sachet) are mixed with sterile water only at the time of use.
• Testing has concluded that it improves the antimicrobial activity of the active pharmaceutical ingredients (APIs).
• Additional testing has shown it increases activity against biofilms.

Take an in-depth look here.

Commonly Written Therapy for

Chronic Sinusitis:

(all therapies non-refrigerated)

Gentamicin 80 mg Capsules Size #1 (LoxaSperse™)
Tobramycin 160 mg Capsules Size #0 (LoxaSperse™)
Vancomycin 200 mg/Betamethasone 0.5 mg/Tobramycin
125 mg Capsule Size #00 (LoxaSperse™)

Don't see what you are looking for? Please call one of our friendly staff members for help (615) 383-3784.

***Most Major Insurances Accepted. Affordable Cash Prices Available***

The NasoNeb® Nasal Nebulizer

The Optimal Intranasal Drug Delivery Solution

The NasoNeb System is the subject of 2 university-based peer reviewed studies published in a prestigious medical journal. 8,10 NasoNeb-delivered pharmaceutical therapy has demonstrated positive outcomes in the treatment arm of a peer-reviewed, university-based, parallel, double-blinded, placebo-controlled trial performed in a perennial allergic rhinitis patient population. 7,8

The NasoNeb® Nasal Nebulizer delivers a deep, penetrating aerosol to the nasal and paranasal sinus cavities that is comfortable to use and offers fast delivery times, with safety advantages over irrigation and small particle nebulizers. 3,6,7,8,10

The patented NasoNeb System features a unique combination of particle size, airflow, and fluid volume. This results in a controlled therapy delivery only to the nasal and paranasal sinus cavities featuring broad intranasal drug deposition, high intranasal drug retention, virtually no pulmonary deposition and is backed by clinical data. 3,7,8,10 » Learn more about the NasoNeb® Nasal Nebulizer.

For Providers: Small Snapshot of Therapies